文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症患者肠道菌群组成与产超广谱β-内酰胺酶肠杆菌目粪便定植的关联(微生物组队列研究)

Bridging gut microbiota composition with extended-spectrum beta-lactamase Enterobacteriales faecal carriage in critically ill patients (microbe cohort study).
PubMed 文献 · Ann Intensive Care · 2023-04-04
一句话结论重症患者中产ESBL大肠埃希菌与产ESBL肺炎克雷伯菌粪便定植者的肠道菌群组成不同,研究菌群与定植关系时应考虑菌种。

该研究纳入255例重症患者,其中11例(4.3%)粪便定植产ESBL大肠埃希菌、6例(2.4%)定植产ESBL肺炎克雷伯菌,与年龄、性别匹配的非定植者比较肠道菌群组成。产ESBL大肠埃希菌定植者与非定植者间无显著差异;产ESBL肺炎克雷伯菌定植者肠道细菌α多样性较非定植者降低(p=0.05),也较产ESBL大肠埃希菌定植者降低。Sellimonas intestinalis的存在与无产ESBL大肠埃希菌粪便定植相关;Campylobacter ureolyticus、Campylobacter hominis、Clostridium cluster XI菌及Saccharomyces sp.与无产ESBL肺炎克雷伯菌粪便定植相关。作者认为肠道菌群组成在产ESBL大肠埃希菌与肺炎克雷伯菌定植者间存在差异,研究菌群对ESBL-E肠道定植抵抗作用时应考虑菌种。

要点

  • 255例重症患者中产ESBL大肠埃希菌粪便定植11例(4.3%),产ESBL肺炎克雷伯菌定植6例(2.4%)。
  • 产ESBL肺炎克雷伯菌粪便定植者肠道细菌α多样性较非定植者降低(p=0.05),也较产ESBL大肠埃希菌定植者降低。
  • 产ESBL大肠埃希菌定植者与非定植者之间未发现显著差异。
  • Sellimonas intestinalis的存在与无产ESBL大肠埃希菌粪便定植相关。
  • Campylobacter ureolyticus、Campylobacter hominis、Clostridium cluster XI菌及Saccharomyces sp.与无产ESBL肺炎克雷伯菌粪便定植相关。

适用人群与场景

  • 重症患者255例,其中产ESBL大肠埃希菌粪便定植11例(4.3%)、产ESBL肺炎克雷伯菌粪便定植6例(2.4%),与年龄、性别匹配的ESBL-E非定植者比较。

研究设计与关键结果

  • 研究类型为微生物组队列研究,纳入255例重症患者,比较产ESBL大肠埃希菌或肺炎克雷伯菌粪便定植者与年龄、性别匹配的ESBL-E非定植者的肠道菌群组成。
  • 产ESBL大肠埃希菌定植者(11例,4.3%)与非定植者之间未发现显著差异。
  • 产ESBL肺炎克雷伯菌粪便定植者(6例,2.4%)肠道细菌α多样性较非定植者降低(p=0.05),也较产ESBL大肠埃希菌定植者降低。
  • Sellimonas intestinalis的存在与无产ESBL大肠埃希菌粪便定植相关。
  • Campylobacter ureolyticus、Campylobacter hominis、Clostridium cluster XI菌及Saccharomyces sp.与无产ESBL肺炎克雷伯菌粪便定植相关。

证据类型、等级与局限

  • 证据类型:微生物组队列研究(microbe cohort study);试验注册号NCT04131569,注册日期2019年10月18日。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,产ESBL大肠埃希菌与产ESBL肺炎克雷伯菌粪便定植者的肠道菌群组成存在差异,研究肠道菌群在ESBL-E肠道定植抵抗中的作用时应考虑微生物菌种。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The worldwide dissemination of extended spectrum beta-lactamase producing Enterobacteriales (ESBL-E) is of major concern. Microbiota may play a role in the host resistance to colonization with ESBL-E, but the underlying mechanisms remain unknown. We aimed to compare the gut microbiota composition between ESBL-producing E. coli or K. pneumoniae carriers and ESBL-E non-carriers according to the bacterial species.

RESULTS: Among 255 patients included, 11 (4,3%) were colonized with ESBL-producing E. coli and 6 (2,4%) with ESBL-producing K. pneumoniae, which were compared with age- and sex-matched ESBL-E non carriers. While no significant differences were found between ESBL-producing E. coli carriers and non-carriers, gut bacteriobiota α-diversity was decreased in ESBL-K. pneumoniae faecal carriers compared both with non-carriers (p = 0.05), and with ESBL-producing E. coli carriers. The presence of Sellimonas intestinalis was associated with the absence of ESBL-producing E. coli fecal carriage. Campylobacter ureolyticus, Campylobacter hominis, bacteria belonging to Clostridium cluster XI and Saccharomyces sp. were associated with the absence of ESBL-producing K. pneumoniae faecal carriage.

CONCLUSIONS: The composition of the gut microbiota differs between ESBL-producing E. coli and K. pneumoniae faecal carriers suggesting that microbial species should be taken into account when investigating the role of gut microbiota in resistance to gut colonization with ESBL-E.

TRIAL REGISTRATION NUMBER: NCT04131569, date of registration: October 18, 2019.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Prevel R, Enaud R, Orieux A, et al. Bridging gut microbiota composition with extended-spectrum beta-lactamase Enterobacteriales faecal carriage in critically ill patients (microbe cohort study). Ann Intensive Care. 2023. PMID: 37014580. doi:10.1186/s13613-023-01121-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。